Author(s)

Hugues de Thé

Presentation

After decades of descriptive studies, the biology of cancer is undergoing a real revolution: with genetic approaches, researchers have identified many of the cell deregulations likely to drive tumours. A treatment combining arsenic and retinoic acid targets the protein responsible for promyelocytic leukaemia. This treatment, which has cured virtually all patients, gives hope that the in-depth understanding of carcinogenesis mechanisms may lead to new therapeutic approaches that could be transposed to other cancers.

Hugues de Thé, a physician and former intern at the Hôpitaux de Paris, with a PhD in science, is head of the biochemistry/molecular biology service at the Hôpital Saint-Louis, head of the research unit UMR “Pathologie et virologie moléculaire” and professor of molecular biology at the Paris-Diderot University. He has been a member of the French Academy of Sciences since 2011 and, in March 2014, was appointed Professor at the Collège de France, where he holds the Chair of Cellular and Molecular Oncology.

ISBN
978-2-7226-0775-0
Publication date
Language
anglais
Translator
Liz Libbrecht
Price
7.99 €
Distribution
OpenEdition
Format
Édition numérique

Table of contents

Serge Haroche : Introduction

Hugues de Thé : Oncology: From Empiricism to Integrative Biology

Same author

All publications from the same author

Same collection

All publications from the same collection